+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Kairomones Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 193 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6121399
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Kairomones Market grew from USD 310.84 million in 2025 to USD 344.49 million in 2026. It is expected to continue growing at a CAGR of 11.00%, reaching USD 645.37 million by 2032.

Kairomones are emerging as precision behavioral tools in pest management, linking chemical ecology to scalable field performance and compliance demands

Kairomones occupy a distinctive position within semiochemical science because they create value through an interspecies signal that benefits the receiver rather than the emitter. In applied settings, that characteristic translates into practical tools that influence insect behavior without relying on broad-spectrum toxicity. As agriculture, forestry, and public health programs pursue more selective interventions, kairomones are increasingly evaluated alongside pheromones, attract-and-kill systems, and biologically derived crop protection inputs.

What makes the category strategically important is not only the underlying chemistry, but the way kairomones fit into modern integrated pest management. When used correctly, they can enhance monitoring sensitivity, support early detection of invasive species, improve trap efficacy, and reduce unnecessary spray events by tightening the link between observed pressure and response. Consequently, kairomones are gaining attention from decision-makers who must meet performance targets while navigating rising resistance concerns, residue scrutiny, and biodiversity expectations.

At the same time, commercialization is shaped by hard realities: formulation stability, controlled release behavior, field longevity, and the practicality of deployment across diverse farm sizes and climates. Moreover, success depends on harmonizing biological performance with procurement needs, regulatory acceptance, and compatibility with existing equipment and grower workflows. This executive summary frames the market’s direction through these operational lenses, highlighting the shifts that matter most for organizations investing in kairomone-enabled solutions.

Shifts toward IPM-first decision models, engineered release systems, and digital monitoring are redefining how kairomones are designed, deployed, and valued

The landscape is being reshaped by a broad shift from chemistry-first pest control toward decision-first pest management, where intervention is triggered by better detection and targeted pressure reduction. In that model, kairomones act as enabling infrastructure: they improve the quality and timeliness of information from traps and lures, and they can also serve as the behavioral “pull” in multi-component systems. As programs mature, the conversation moves beyond whether kairomones work to how reliably they work across crops, seasons, and operational constraints.

Another transformative shift is the acceleration of product engineering around release kinetics and durability. End users are less willing to accept frequent lure replacement or inconsistent plume behavior across temperature swings, which pushes suppliers toward improved dispensers, microencapsulation approaches, and matrix materials that maintain consistent emission profiles. This is also prompting closer collaboration between chemical ecologists, formulation chemists, and device designers, because performance is increasingly viewed as an integrated system rather than a standalone active ingredient.

Digital agriculture is also altering expectations. Growers and pest control operators want monitoring outputs that can be captured, analyzed, and acted on quickly. While kairomones are not inherently digital, they increasingly sit inside digital workflows through smart traps, image-based species identification, and dashboard-driven advisories. This creates a feedback loop: better lures improve trap signal-to-noise, which improves model quality, which in turn increases demand for consistent kairomone performance and standardized deployment protocols.

Finally, sustainability governance is shifting from voluntary claims to auditable outcomes. This raises the bar on documentation for product stewardship, non-target impacts, and compatibility with regenerative and organic-adjacent programs. As a result, organizations are placing more emphasis on traceability of feedstocks, quality management systems, and the ability to supply consistent lots over time. In combination, these shifts are compressing development timelines for differentiated offerings while raising requirements for reliability, compliance readiness, and integration with broader IPM strategies.

The cumulative impact of 2025 U.S. tariffs is reshaping kairomone supply chains, landed-cost management, and localization decisions across lure systems

United States tariff dynamics in 2025 are expected to influence kairomone commercialization primarily through cost structure volatility, supplier qualification decisions, and the pace of localization for certain inputs. Even when kairomone actives are used at low loadings, the overall bill of materials can be sensitive to tariffs because dispensers, packaging, specialty polymers, and certain chemical intermediates often move through cross-border supply chains. As a result, procurement teams are paying closer attention to tariff classification, country-of-origin documentation, and the total landed cost of finished lure systems rather than just the price of the active component.

A cumulative effect of tariff uncertainty is the reinforcement of dual-sourcing strategies. Organizations that previously relied on a single low-cost route for intermediates are increasingly qualifying alternate suppliers in the United States or in tariff-neutral corridors to protect continuity. This can raise near-term qualification and validation work, particularly where changes in raw material provenance require re-verification of impurity profiles or emission characteristics. Over time, however, these efforts can strengthen resilience by reducing the likelihood of stockouts during peak seasonal demand.

Tariffs may also influence manufacturing footprint decisions. For some suppliers, assembling final lure products domestically-while sourcing certain intermediates globally-can reduce exposure, shorten lead times, and improve responsiveness to customer orders tied to pest outbreaks or sudden regulatory constraints on conventional pesticides. For others, the economics may favor regional hub models that balance tariff exposure with scale efficiency, especially when serving customers across North America with tight delivery windows.

Importantly, pricing conversations are becoming more nuanced. Buyers are increasingly willing to consider multi-year agreements or volume commitments if suppliers can demonstrate stability in supply and clear mechanisms for managing tariff-driven cost swings. In parallel, sales teams are being asked to justify value in operational terms-reduced scouting labor, fewer unnecessary applications, improved detection accuracy-because input price sensitivity can rise when external cost pressures accumulate. In this environment, the organizations that combine transparent sourcing governance with measurable field outcomes are better positioned to maintain adoption momentum.

Segmentation insights reveal distinct buying logics by type, application, form, end user, and channel, making product-market fit a system-level challenge

Segmentation patterns show that demand drivers differ meaningfully depending on how kairomones are formulated, where they are deployed, and which decision-maker owns the budget. Across Type, plant-derived kairomones and insect-derived kairomones are often evaluated through different lenses: plant-origin cues can be framed around host-location and crop-specific attraction, while insect-origin cues may align more closely with pest ecology, aggregation behaviors, or predator-prey interactions. This distinction matters because it influences how products are positioned, how field trials are designed, and which partners-crop input suppliers, monitoring service providers, or public agencies-are most likely to champion adoption.

Across Application, agriculture and forestry frequently prioritize early detection and season-long monitoring fidelity, whereas public health programs tend to emphasize reliability under diverse urban and peri-urban conditions and the ability to support rapid response. In stored product protection and other controlled environments, consistency and contamination avoidance become central, which can elevate preferences for specific dispenser materials and validated emission stability. As these application contexts diverge, suppliers are increasingly tailoring claims, packaging formats, and replenishment schedules to the operational tempo of each use case.

Across Form, liquid, solid, and microencapsulated formats compete on ease of handling, release control, and robustness in the field. Liquid formats can offer formulation flexibility and may be favored in certain impregnation or coating processes, but they can introduce handling constraints. Solid matrices and impregnated substrates often simplify deployment and standardize performance, while microencapsulation is increasingly associated with more controlled release profiles and improved stability under challenging environmental conditions. In practice, the most successful suppliers treat format selection as a system decision that includes trap design, target pest biology, and replacement labor economics.

Across End User, farmers, pest control operators, and government agencies tend to value different outcomes and procurement pathways. Farmers often focus on practicality, compatibility with farm routines, and clear thresholds for action. Pest control operators prioritize repeatable performance across sites, service efficiency, and customer reporting. Government agencies weigh public accountability, scalability across jurisdictions, and procurement compliance, often requiring more extensive documentation. These differences are shaping go-to-market strategies, with suppliers building distinct evidence packages and support materials tailored to each buyer’s decision criteria.

Across Distribution Channel, direct sales and distributors coexist, but their roles are evolving. Direct engagement can be critical when products require training, protocol design, or integration with digital monitoring platforms. Distributors, meanwhile, remain essential for reach, seasonal availability, and bundling with traps or complementary inputs. As the category matures, hybrid approaches are becoming more common, where technical onboarding is handled directly while replenishment and logistics flow through established channel partners. This segmentation reality underscores a core insight: performance alone does not win; adoption depends on fit with operational workflows, proof standards, and purchasing behaviors across segments.

Regional insights across the Americas, Europe Middle East & Africa, and Asia-Pacific show adoption shaped by IPM maturity, regulation, and field logistics

Regional dynamics are strongly shaped by regulatory norms, pest pressure, and the maturity of integrated pest management programs, which means adoption pathways for kairomones can look very different across markets. In the Americas, growers and service providers often look for solutions that can be deployed at scale with clear operational payback, especially in high-value specialty crops and in programs targeting invasive pests. There is also a strong emphasis on consistent seasonal supply and documentation that supports retailer and export requirements, which elevates the importance of quality systems and reliable logistics.

In Europe, Middle East & Africa, the push toward reduced-risk plant protection and biodiversity considerations continues to influence procurement choices. Many buyers prioritize evidence that supports selective targeting and stewardship, and they often expect robust technical documentation and compatibility with broader IPM protocols. Diverse climatic zones and cropping systems across the region can amplify the need for localized validation, while public-sector involvement in certain pest programs can increase the importance of procurement compliance and standardization.

In Asia-Pacific, growth in intensification, export-oriented production, and rapid technology adoption are creating multiple entry points for kairomone-enabled systems. In some markets, labor constraints and the expansion of digital farming tools are strengthening the appeal of improved monitoring and decision support. At the same time, the region’s diversity in farm size, infrastructure, and regulatory frameworks means suppliers must carefully adapt packaging, training, and channel strategy to local realities. Across all regions, a common theme is emerging: buyers increasingly want solutions that are not only effective, but also easy to deploy, auditable, and resilient to supply disruptions.

Company insights highlight differentiation through system performance, partnerships, and quality discipline as buyers prioritize repeatability, scale, and support

The competitive environment is characterized by a mix of specialized semiochemical suppliers, broader crop input players extending into behavioral solutions, and device-focused innovators integrating lures with advanced trapping systems. Differentiation is increasingly anchored in reliability and usability rather than novelty alone, with buyers scrutinizing field longevity, lot-to-lot consistency, and the clarity of deployment protocols. Companies that can demonstrate repeatable outcomes across geographies and seasons tend to earn preferred-supplier status, especially when products support standardized monitoring networks.

Partnerships are becoming a central feature of company strategy. Many organizations are pairing kairomone chemistry expertise with dispenser engineering, contract manufacturing scale, or distribution reach. This is particularly important when serving large acreage programs or public monitoring initiatives that demand consistent supply and predictable replenishment cycles. In parallel, collaborations with research institutions and extension networks can accelerate validation and strengthen credibility, provided that trial designs reflect real-world operational constraints.

Intellectual property and know-how remain critical, but the basis of advantage is shifting toward integrated system performance. That includes proprietary blends, impurity control, and optimized release materials, as well as documentation that supports regulatory and stewardship expectations. Companies that invest in quality management, scalable manufacturing, and technical support capabilities are better positioned to convert pilot activity into repeat purchasing, especially when customers must coordinate multiple stakeholders around monitoring thresholds and response actions.

Actionable recommendations focus on system-level value proof, release engineering discipline, tariff-resilient sourcing, and digital workflow integration

Industry leaders can strengthen their position by treating kairomones as part of an end-to-end decision system rather than a standalone product. That starts with designing offerings around measurable operational outcomes such as improved detection confidence, reduced scouting time, and clearer intervention thresholds. When commercial teams can translate performance into workflow impact, they are better equipped to defend value in procurement discussions that are increasingly sensitive to landed-cost fluctuations.

Next, leaders should invest in release engineering and quality governance with the same rigor applied to active discovery. Standardizing emission profiles, tightening impurity specifications, and validating dispenser performance across temperature and humidity ranges can reduce customer friction and lower the cost of technical support. In addition, building robust documentation packages-covering storage conditions, field handling, and non-target considerations-helps accelerate approvals and strengthens stewardship alignment with sustainability programs.

Supply-chain resilience should be addressed proactively in light of tariff-driven uncertainty. Qualifying alternate sources for key intermediates, diversifying dispenser and packaging suppliers, and maintaining clear country-of-origin and tariff classification records can reduce disruption risk. Where feasible, leaders can explore regional finishing or assembly models that shorten lead times during peak seasons and provide flexibility when cross-border costs shift.

Finally, organizations should deepen integration with digital monitoring ecosystems. Even without owning the entire stack, suppliers can publish deployment protocols that align with smart trap data capture, support APIs or standardized data fields where relevant, and collaborate with platform providers on calibration and validation. By meeting customers where decisions are made-on dashboards and in field service schedules-leaders can embed kairomones into repeatable programs rather than episodic trials.

Research methodology integrates secondary technical review with primary value-chain validation to reflect real deployment constraints and buyer decision criteria

The research approach combines structured secondary review with primary validation to ensure the analysis reflects both scientific realities and commercial constraints. Secondary work evaluates developments in chemical ecology applications, dispenser technologies, regulatory patterns, and deployment models across agriculture, forestry, and public health contexts. This is complemented by review of publicly available company materials, product documentation, patent activity signals, and standards that influence quality and stewardship expectations.

Primary insights are developed through interviews and consultations with stakeholders across the value chain, including product developers, formulation and manufacturing specialists, channel partners, pest management practitioners, and institutional program operators. These conversations are used to validate how kairomones are selected, tested, purchased, and deployed, and to understand the operational trade-offs that influence adoption. Emphasis is placed on identifying repeatable decision criteria such as field longevity, ease of use, documentation needs, and compatibility with traps and monitoring workflows.

Findings are triangulated to reduce bias and to reconcile differences between laboratory performance narratives and field realities. The methodology also applies consistency checks across segments and regions to ensure that insights reflect differences in procurement norms, regulatory expectations, and supply-chain structures. Throughout, the goal is to provide decision-ready analysis that helps readers compare strategic options, understand adoption barriers, and prioritize investments in product engineering, partnerships, and commercialization pathways.

Conclusion underscores kairomones as dependable IPM infrastructure when science, engineering, supply resilience, and user workflows are aligned for repeatability

Kairomones are moving from niche tools to more structured components of modern pest management, driven by the need for selectivity, better monitoring, and operationally efficient decision-making. As the landscape shifts, the most consequential changes are less about the basic promise of semiochemicals and more about execution: engineered release performance, field reliability, documentation rigor, and integration into service and digital workflows.

Tariff and supply-chain pressures in 2025 add urgency to resilience planning, pushing organizations to examine sourcing, manufacturing footprint, and total landed cost with greater discipline. Meanwhile, segmentation differences across type, application, form, end user, and channel reinforce that there is no single go-to-market model; success depends on tailoring evidence, packaging, and support to the decision-maker and deployment context.

Ultimately, organizations that combine scientific credibility with manufacturing consistency, channel strategy, and measurable operational value will be best positioned to expand adoption. By focusing on system performance and repeatability, suppliers and buyers alike can turn kairomones into dependable infrastructure for monitoring, targeted intervention, and long-term stewardship goals.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Kairomones Market, by Type
8.1. Non Volatile
8.1.1. Peptides
8.1.2. Proteins
8.2. Volatile
8.2.1. Nitrogen Volatiles
8.2.2. Sulfur Volatiles
9. Kairomones Market, by Source
9.1. Natural
9.1.1. Animal Derived
9.1.2. Microbial Derived
9.1.3. Plant Derived
9.2. Synthetic
9.2.1. Biotechnology
9.2.2. Chemical Synthesis
10. Kairomones Market, by Formulation
10.1. Gas
10.1.1. Aerosol
10.1.2. Vapor
10.2. Liquid
10.2.1. Emulsion
10.2.2. Solution
10.3. Solid
10.3.1. Granule
10.3.2. Powder
11. Kairomones Market, by Application
11.1. Animal Behavior Research
11.2. Environmental Monitoring
11.3. Pest Control
11.3.1. Crop Protection
11.3.2. Urban Pest Control
11.4. Pharmaceutical
11.5. Plant Defense Research
12. Kairomones Market, by End User
12.1. Academic & Research Institutes
12.1.1. Research Laboratories
12.1.2. Universities
12.2. Agriculture
12.2.1. Crop Protection
12.2.2. Livestock Management
12.3. Biotechnology & Pharma
12.3.1. Biotechnology
12.3.2. Pharmaceutical
12.4. Cosmetics
13. Kairomones Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Kairomones Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Kairomones Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Kairomones Market
17. China Kairomones Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. AgriSense-BCS Ltd.
18.6. Andermatt Biocontrol AG
18.7. BASF SE
18.8. Bedoukian Research Inc.
18.9. Biobest Group NV
18.10. BioControle
18.11. Certis USA LLC
18.12. Hercon Environmental Corporation
18.13. ISCA Technologies Inc.
18.14. Koppert Biological Systems
18.15. Pheromone Chemicals Pvt. Ltd.
18.16. Russell IPM Ltd.
18.17. Shin-Etsu Chemical Co. Ltd.
18.18. Suterra LLC
18.19. Trécé Incorporated
List of Figures
FIGURE 1. GLOBAL KAIROMONES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL KAIROMONES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL KAIROMONES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL KAIROMONES MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL KAIROMONES MARKET SIZE, BY SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL KAIROMONES MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL KAIROMONES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL KAIROMONES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL KAIROMONES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL KAIROMONES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL KAIROMONES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES KAIROMONES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA KAIROMONES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL KAIROMONES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL KAIROMONES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL KAIROMONES MARKET SIZE, BY NON VOLATILE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL KAIROMONES MARKET SIZE, BY NON VOLATILE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL KAIROMONES MARKET SIZE, BY NON VOLATILE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL KAIROMONES MARKET SIZE, BY NON VOLATILE, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL KAIROMONES MARKET SIZE, BY PEPTIDES, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL KAIROMONES MARKET SIZE, BY PEPTIDES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL KAIROMONES MARKET SIZE, BY PEPTIDES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL KAIROMONES MARKET SIZE, BY PROTEINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL KAIROMONES MARKET SIZE, BY PROTEINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL KAIROMONES MARKET SIZE, BY PROTEINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL KAIROMONES MARKET SIZE, BY VOLATILE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL KAIROMONES MARKET SIZE, BY VOLATILE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL KAIROMONES MARKET SIZE, BY VOLATILE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL KAIROMONES MARKET SIZE, BY VOLATILE, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL KAIROMONES MARKET SIZE, BY NITROGEN VOLATILES, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL KAIROMONES MARKET SIZE, BY NITROGEN VOLATILES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL KAIROMONES MARKET SIZE, BY NITROGEN VOLATILES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL KAIROMONES MARKET SIZE, BY SULFUR VOLATILES, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL KAIROMONES MARKET SIZE, BY SULFUR VOLATILES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL KAIROMONES MARKET SIZE, BY SULFUR VOLATILES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL KAIROMONES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL KAIROMONES MARKET SIZE, BY NATURAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL KAIROMONES MARKET SIZE, BY NATURAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL KAIROMONES MARKET SIZE, BY NATURAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL KAIROMONES MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL KAIROMONES MARKET SIZE, BY ANIMAL DERIVED, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL KAIROMONES MARKET SIZE, BY ANIMAL DERIVED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL KAIROMONES MARKET SIZE, BY ANIMAL DERIVED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL KAIROMONES MARKET SIZE, BY MICROBIAL DERIVED, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL KAIROMONES MARKET SIZE, BY MICROBIAL DERIVED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL KAIROMONES MARKET SIZE, BY MICROBIAL DERIVED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL KAIROMONES MARKET SIZE, BY PLANT DERIVED, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL KAIROMONES MARKET SIZE, BY PLANT DERIVED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL KAIROMONES MARKET SIZE, BY PLANT DERIVED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL KAIROMONES MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL KAIROMONES MARKET SIZE, BY SYNTHETIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL KAIROMONES MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL KAIROMONES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL KAIROMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL KAIROMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL KAIROMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL KAIROMONES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL KAIROMONES MARKET SIZE, BY GAS, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL KAIROMONES MARKET SIZE, BY GAS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL KAIROMONES MARKET SIZE, BY GAS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL KAIROMONES MARKET SIZE, BY GAS, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL KAIROMONES MARKET SIZE, BY AEROSOL, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL KAIROMONES MARKET SIZE, BY AEROSOL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL KAIROMONES MARKET SIZE, BY AEROSOL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL KAIROMONES MARKET SIZE, BY VAPOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL KAIROMONES MARKET SIZE, BY VAPOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL KAIROMONES MARKET SIZE, BY VAPOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL KAIROMONES MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL KAIROMONES MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL KAIROMONES MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL KAIROMONES MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL KAIROMONES MARKET SIZE, BY EMULSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL KAIROMONES MARKET SIZE, BY EMULSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL KAIROMONES MARKET SIZE, BY EMULSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL KAIROMONES MARKET SIZE, BY SOLUTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL KAIROMONES MARKET SIZE, BY SOLUTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL KAIROMONES MARKET SIZE, BY SOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL KAIROMONES MARKET SIZE, BY SOLID, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL KAIROMONES MARKET SIZE, BY SOLID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL KAIROMONES MARKET SIZE, BY SOLID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL KAIROMONES MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL KAIROMONES MARKET SIZE, BY GRANULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL KAIROMONES MARKET SIZE, BY GRANULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL KAIROMONES MARKET SIZE, BY GRANULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL KAIROMONES MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL KAIROMONES MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL KAIROMONES MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL KAIROMONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL KAIROMONES MARKET SIZE, BY ANIMAL BEHAVIOR RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL KAIROMONES MARKET SIZE, BY ANIMAL BEHAVIOR RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL KAIROMONES MARKET SIZE, BY ANIMAL BEHAVIOR RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL KAIROMONES MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL KAIROMONES MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL KAIROMONES MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL KAIROMONES MARKET SIZE, BY PEST CONTROL, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL KAIROMONES MARKET SIZE, BY PEST CONTROL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL KAIROMONES MARKET SIZE, BY PEST CONTROL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL KAIROMONES MARKET SIZE, BY PEST CONTROL, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL KAIROMONES MARKET SIZE, BY CROP PROTECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL KAIROMONES MARKET SIZE, BY CROP PROTECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL KAIROMONES MARKET SIZE, BY CROP PROTECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL KAIROMONES MARKET SIZE, BY URBAN PEST CONTROL, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL KAIROMONES MARKET SIZE, BY URBAN PEST CONTROL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL KAIROMONES MARKET SIZE, BY URBAN PEST CONTROL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL KAIROMONES MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL KAIROMONES MARKET SIZE, BY PHARMACEUTICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL KAIROMONES MARKET SIZE, BY PHARMACEUTICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL KAIROMONES MARKET SIZE, BY PLANT DEFENSE RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL KAIROMONES MARKET SIZE, BY PLANT DEFENSE RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL KAIROMONES MARKET SIZE, BY PLANT DEFENSE RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL KAIROMONES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL KAIROMONES MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL KAIROMONES MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL KAIROMONES MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL KAIROMONES MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL KAIROMONES MARKET SIZE, BY UNIVERSITIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL KAIROMONES MARKET SIZE, BY UNIVERSITIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL KAIROMONES MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL KAIROMONES MARKET SIZE, BY AGRICULTURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL KAIROMONES MARKET SIZE, BY AGRICULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL KAIROMONES MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL KAIROMONES MARKET SIZE, BY CROP PROTECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL KAIROMONES MARKET SIZE, BY CROP PROTECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL KAIROMONES MARKET SIZE, BY CROP PROTECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL KAIROMONES MARKET SIZE, BY LIVESTOCK MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL KAIROMONES MARKET SIZE, BY LIVESTOCK MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL KAIROMONES MARKET SIZE, BY LIVESTOCK MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL KAIROMONES MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL KAIROMONES MARKET SIZE, BY PHARMACEUTICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL KAIROMONES MARKET SIZE, BY PHARMACEUTICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL KAIROMONES MARKET SIZE, BY COSMETICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL KAIROMONES MARKET SIZE, BY COSMETICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL KAIROMONES MARKET SIZE, BY COSMETICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL KAIROMONES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS KAIROMONES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS KAIROMONES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 138. AMERICAS KAIROMONES MARKET SIZE, BY NON VOLATILE, 2018-2032 (USD MILLION)
TABLE 139. AMERICAS KAIROMONES MARKET SIZE, BY VOLATILE, 2018-2032 (USD MILLION)
TABLE 140. AMERICAS KAIROMONES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 141. AMERICAS KAIROMONES MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
TABLE 142. AMERICAS KAIROMONES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
TABLE 143. AMERICAS KAIROMONES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 144. AMERICAS KAIROMONES MARKET SIZE, BY GAS, 2018-2032 (USD MILLION)
TABLE 145. AMERICAS KAIROMONES MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 146. AMERICAS KAIROMONES MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
TABLE 147. AMERICAS KAIROMONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 148. AMERICAS KAIROMONES MARKET SIZE, BY PEST CONTROL, 2018-2032 (USD MILLION)
TABLE 149. AMERICAS KAIROMONES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 150. AMERICAS KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 151. AMERICAS KAIROMONES MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
TABLE 152. AMERICAS KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, 2018-2032 (USD MILLION)
TABLE 153. NORTH AMERICA KAIROMONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. NORTH AMERICA KAIROMONES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 155. NORTH AMERICA KAIROMONES MARKET SIZE, BY NON VOLATILE, 2018-2032 (USD MILLION)
TABLE 156. NORTH AMERICA KAIROMONES MARKET SIZE, BY VOLATILE, 2018-2032 (USD MILLION)
TABLE 157. NORTH AMERICA KAIROMONES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 158. NORTH AMERICA KAIROMONES MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
TABLE 159. NORTH AMERICA KAIROMONES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
TABLE 160. NORTH AMERICA KAIROMONES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 161. NORTH AMERICA KAIROMONES MARKET SIZE, BY GAS, 2018-2032 (USD MILLION)
TABLE 162. NORTH AMERICA KAIROMONES MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 163. NORTH AMERICA KAIROMONES MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
TABLE 164. NORTH AMERICA KAIROMONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 165. NORTH AMERICA KAIROMONES MARKET SIZE, BY PEST CONTROL, 2018-2032 (USD MILLION)
TABLE 166. NORTH AMERICA KAIROMONES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 167. NORTH AMERICA KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 168. NORTH AMERICA KAIROMONES MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
TABLE 169. NORTH AMERICA KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, 2018-2032 (USD MILLION)
TABLE 170. LATIN AMERICA KAIROMONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. LATIN AMERICA KAIROMONES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 172. LATIN AMERICA KAIROMONES MARKET SIZE, BY NON VOLATILE, 2018-2032 (USD MILLION)
TABLE 173. LATIN AMERICA KAIROMONES MARKET SIZE, BY VOLATILE, 2018-2032 (USD MILLION)
TABLE 174. LATIN AMERICA KAIROMONES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 175. LATIN AMERICA KAIROMONES MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
TABLE 176. LATIN AMERICA KAIROMONES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
TABLE 177. LATIN AMERICA KAIROMONES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 178. LATIN AMERICA KAIROMONES MARKET SIZE, BY GAS, 2018-2032 (USD MILLION)
TABLE 179. LATIN AMERICA KAIROMONES MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 180. LATIN AMERICA KAIROMONES MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
TABLE 181. LATIN AMERICA KAIROMONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 182. LATIN AMERICA KAIROMONES MARKET SIZE, BY PEST CONTROL, 2018-2032 (USD MILLION)
TABLE 183. LATIN AMERICA KAIROMONES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 184. LATIN AMERICA KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 185. LATIN AMERICA KAIROMONES MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
TABLE 186. LATIN AMERICA KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, 2018-2032 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY NON VOLATILE, 2018-2032 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY VOLATILE, 2018-2032 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY GAS, 2018-2032 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY PEST CONTROL, 2018-2032 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, 2018-2032 (USD MILLION)
TABLE 204. EUROPE KAIROMONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. EUROPE KAIROMONES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 206. EUROPE KAIROMONES MARKET SIZE, BY NON VOLATILE, 2018-2032 (USD MILLION)
TABLE 207. EUROPE KAIROMONES MARKET SIZE, BY VOLATILE, 2018-2032 (USD MILLION)
TABLE 208. EUROPE KAIROMONES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 209. EUROPE KAIROMONES MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
TABLE 210. EUROPE KAIROMONES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
TABLE 211. EUROPE KAIROMONES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 212. EUROPE KAIROMONES MARKET SIZE, BY GAS, 2018-2032 (USD MILLION)
TABLE 213. EUROPE KAIROMONES MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 214. EUROPE KAIROMONES MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
TABLE 215. EUROPE KAIROMONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 216. EUROPE KAIROMONES MARKET SIZE, BY PEST CONTROL, 2018-2032 (USD MILLION)
TABLE 217. EUROPE KAIROMONES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 218. EUROPE KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 219. EUROPE KAIROMONES MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
TABLE 220. EUROPE KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, 2018-2032 (USD MILLION)
TABLE 221. MIDDLE EAST KAIROMONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 222. MIDDLE EAST KAIROMONES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 223. MIDDLE EAST KAIROMONES MARKET SIZE, BY NON VOLATILE, 2018-2032 (USD MILLION)
TABLE 224. MIDDLE EAST KAIROMONES MARKET SIZE, BY VOLATILE, 2018-2032 (USD MILLION)
TABLE 225. MIDDLE EAST KAIROMONES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 226. MIDDLE EAST KAIROMONES MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
TABLE 227. MIDDLE EAST KAIROMONES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
TABLE 228. MIDDLE EAST KAIROMONES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 229. MIDDLE EAST KAIROMONES MARKET SIZE, BY GAS, 2018-2032 (USD MILLION)
TABLE 230. MIDDLE EAST KAIROMONES MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 231. MIDDLE EAST KAIROMONES MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
TABLE 232. MIDDLE EAST KAIROMONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 233. MIDDLE EAST KAIROMONES MARKET SIZE, BY PEST CONTROL, 2018-2032 (USD MILLION)
TABLE 234. MIDDLE EAST KAIROMONES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 235. MIDDLE EAST KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 236. MIDDLE EAST KAIROMONES MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
TABLE 237. MIDDLE EAST KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, 2018-2032 (USD MILLION)
TABLE 238. AFRICA KAIROMONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 239. AFRICA KAIROMONES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 240. AFRICA KAIROMONES MARKET SIZE, BY NON VOLATILE, 2018-2032 (USD MILLION)
TABLE 241. AFRICA KAIROMONES MARKET SIZE, BY VOLATILE, 2018-2032 (USD MILLION)
TABLE 242. AFRICA KAIROMONES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 243. AFRICA KAIROMONES MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
TABLE 244. AFRICA KAIROMONES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
TABLE 245. AFRICA KAIROMONES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 246. AFRICA KAIROMONES MARKET SIZE, BY GAS, 2018-2032 (USD MILLION)
TABLE 247. AFRICA KAIROMONES MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 248. AFRICA KAIROMONES MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
TABLE 249. AFRICA KAIROMONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 250. AFRICA KAIROMONES MARKET SIZE, BY PEST CONTROL, 2018-2032 (USD MILLION)
TABLE 251. AFRICA KAIROMONES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 252. AFRICA KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 253. AFRICA KAIROMONES MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
TABLE 254. AFRICA KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, 2018-2032 (USD MILLION)
TABLE 255. ASIA-PACIFIC KAIROMONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 256. ASIA-PACIFIC KAIROMONES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 257. ASIA-PACIFIC KAIROMONES MARKET SIZE, BY NON VOLATILE, 2018-2032 (USD MILLION)
TABLE 258. ASIA-PACIFIC KAIROMONES MARKET SIZE, BY VOLATILE, 2018-2032 (USD MILLION)
TABLE 259. ASIA-PACIFIC KAIROMONES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 260. ASIA-PACIFIC KAIROMONES MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
TABLE 261. ASIA-PACIFIC KAIROMONES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
TABLE 262. ASIA-PACIFIC KAIROMONES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 263. ASIA-PACIFIC KAIROMONES MARKET SIZE, BY GAS, 2018-2032 (USD MILLION)
TABLE 264. ASIA-PACIFIC KAIROMONES MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 265. ASIA-PACIFIC KAIROMONES MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
TABLE 266. ASIA-PACIFIC KAIROMONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 267. ASIA-PACIFIC KAIROMONES MARKET SIZE, BY PEST CONTROL, 2018-2032 (USD MILLION)
TABLE 268. ASIA-PACIFIC KAIROMONES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 269. ASIA-PACIFIC KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 270. ASIA-PACIFIC KAIROMONES MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
TABLE 271. ASIA-PACIFIC KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, 2018-2032 (USD MILLION)
TABLE 272. GLOBAL KAIROMONES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 273. ASEAN KAIROMONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 274. ASEAN KAIROMONES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 275. ASEAN KAIROMONES MARKET SIZE, BY NON VOLATILE, 2018-2032 (USD MILLION)
TABLE 276. ASEAN KAIROMONES MARKET SIZE, BY VOLATILE, 2018-2032 (USD MILLION)
TABLE 277. ASEAN KAIROMONES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 278. ASEAN KAIROMONES MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
TABLE 279. ASEAN KAIROMONES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
TABLE 280. ASEAN KAIROMONES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 281. ASEAN KAIROMONES MARKET SIZE, BY GAS, 2018-2032 (USD MILLION)
TABLE 282. ASEAN KAIROMONES MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 283. ASEAN KAIROMONES MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
TABLE 284. ASEAN KAIROMONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 285. ASEAN KAIROMONES MARKET SIZE, BY PEST CONTROL, 2018-2032 (USD MILLION)
TABLE 286. ASEAN KAIROMONES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 287. ASEAN KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 288. ASEAN KAIROMONES MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
TABLE 289. ASEAN KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, 2018-2032 (USD MILLION)
TABLE 290. GCC KAIROMONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 291. GCC KAIROMONES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 292. GCC KAIROMONES MARKET SIZE, BY NON VOLATILE, 2018-2032 (USD MILLION)
TABLE 293. GCC KAIROMONES MARKET SIZE, BY VOLATILE, 2018-2032 (USD MILLION)
TABLE 294. GCC KAIROMONES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 295. GCC KAIROMONES MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
TABLE 296. GCC KAIROMONES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
TABLE 297. GCC KAIROMONES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 298. GCC KAIROMONES MARKET SIZE, BY GAS, 2018-2032 (USD MILLION)
TABLE 299. GCC KAIROMONES MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 300. GCC KAIROMONES MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
TABLE 301. GCC KAIROMONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 302. GCC KAIROMONES MARKET SIZE, BY PEST CONTROL, 2018-2032 (USD MILLION)
TABLE 303. GCC KAIROMONES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 304. GCC KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 305. GCC KAIROMONES MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
TABLE 306. GCC KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, 2018-2032 (USD MILLION)
TABLE 307. EUROPEAN UNION KAIROMONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 308. EUROPEAN UNION KAIROMONES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 309. EUROPEAN UNION KAIROMONES MARKET SIZE, BY NON VOLATILE, 2018-2032 (USD MILLION)
TABLE 310. EUROPEAN UNION KAIROMONES MARKET SIZE, BY VOLATILE, 2018-2032 (USD MILLION)
TABLE 311. EUROPEAN UNION KAIROMONES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 312. EUROPEAN UNION KAIROMONES MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
TABLE 313. EUROPEAN UNION KAIROMONES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
TABLE 314. EUROPEAN UNION KAIROMONES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 315. EUROPEAN UNION KAIROMONES MARKET SIZE, BY GAS, 2018-2032 (USD MILLION)
TABLE 316. EUROPEAN UNION KAIROMONES MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 317. EUROPEAN UNION KAIROMONES MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
TABLE 318. EUROPEAN UNION KAIROMONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 319. EUROPEAN UNION KAIROMONES MARKET SIZE, BY PEST CONTROL, 2018-2032 (USD MILLION)
TABLE 320. EUROPEAN UNION KAIROMONES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 321. EUROPEAN UNION KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 322. EUROPEAN UNION KAIROMONES MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
TABLE 323. EUROPEAN UNION KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, 2018-2032 (USD MILLION)
TABLE 324. BRICS KAIROMONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 325. BRICS KAIROMONES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 326. BRICS KAIROMONES MARKET SIZE, BY NON VOLATILE, 2018-2032 (USD MILLION)
TABLE 327. BRICS KAIROMONES MARKET SIZE, BY VOLATILE, 2018-2032 (USD MILLION)
TABLE 328. BRICS KAIROMONES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 329. BRICS KAIROMONES MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
TABLE 330. BRICS KAIROMONES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
TABLE 331. BRICS KAIROMONES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 332. BRICS KAIROMONES MARKET SIZE, BY GAS, 2018-2032 (USD MILLION)
TABLE 333. BRICS KAIROMONES MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 334. BRICS KAIROMONES MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
TABLE 335. BRICS KAIROMONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 336. BRICS KAIROMONES MARKET SIZE, BY PEST CONTROL, 2018-2032 (USD MILLION)
TABLE 337. BRICS KAIROMONES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 338. BRICS KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 339. BRICS KAIROMONES MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
TABLE 340. BRICS KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, 2018-2032 (USD MILLION)
TABLE 341. G7 KAIROMONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 342. G7 KAIROMONES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 343. G7 KAIROMONES MARKET SIZE, BY NON VOLATILE, 2018-2032 (USD MILLION)
TABLE 344. G7 KAIROMONES MARKET SIZE, BY VOLATILE, 2018-2032 (USD MILLION)
TABLE 345. G7 KAIROMONES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 346. G7 KAIROMONES MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
TABLE 347. G7 KAIROMONES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
TABLE 348. G7 KAIROMONES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 349. G7 KAIROMONES MARKET SIZE, BY GAS, 2018-2032 (USD MILLION)
TABLE 350. G7 KAIROMONES MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 351. G7 KAIROMONES MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
TABLE 352. G7 KAIROMONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 353. G7 KAIROMONES MARKET SIZE, BY PEST CONTROL, 2018-2032 (USD MILLION)
TABLE 354. G7 KAIROMONES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 355. G7 KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 356. G7 KAIROMONES MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
TABLE 357. G7 KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, 2018-2032 (USD MILLION)
TABLE 358. NATO KAIROMONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 359. NATO KAIROMONES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 360. NATO KAIROMONES MARKET SIZE, BY NON VOLATILE, 2018-2032 (USD MILLION)
TABLE 361. NATO KAIROMONES MARKET SIZE, BY VOLATILE, 2018-2032 (USD MILLION)
TABLE 362. NATO KAIROMONES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 363. NATO KAIROMONES MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
TABLE 364. NATO KAIROMONES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
TABLE 365. NATO KAIROMONES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 366. NATO KAIROMONES MARKET SIZE, BY GAS, 2018-2032 (USD MILLION)
TABLE 367. NATO KAIROMONES MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 368. NATO KAIROMONES MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
TABLE 369. NATO KAIROMONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 370. NATO KAIROMONES MARKET SIZE, BY PEST CONTROL, 2018-2032 (USD MILLION)
TABLE 371. NATO KAIROMONES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 372. NATO KAIROMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 373. NATO KAIROMONES MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
TABLE 374. NATO KAIROMONES MARKET SIZE, BY BIOTECHNOLOGY & PHARMA, 2018-2032 (USD MILLION)
TABLE 375. GLOBAL KAIROMONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 376. UNITED STATES KAIROMONES MARKET SIZE, 2018

Companies Mentioned

The key companies profiled in this Kairomones market report include:
  • AgriSense-BCS Ltd.
  • Andermatt Biocontrol AG
  • BASF SE
  • Bedoukian Research Inc.
  • Biobest Group NV
  • BioControle
  • Certis USA LLC
  • Hercon Environmental Corporation
  • ISCA Technologies Inc.
  • Koppert Biological Systems
  • Pheromone Chemicals Pvt. Ltd.
  • Russell IPM Ltd.
  • Shin-Etsu Chemical Co. Ltd.
  • Suterra LLC
  • Trécé Incorporated

Table Information